# OnCo record ralf-gutzmer (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ralf-gutzmer/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ralf-gutzmer" ;
  schema:name "Ralf Gutzmer"@en ;
  schema:description "German dermato-oncologist who was lead author of IMspire150, the trial that added atezolizumab to vemurafenib and cobimetinib in BRAF-mutant melanoma."@en ;
  schema:url <https://onco.cc/people/ralf-gutzmer/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "melanoma", "immunotherapy", "trialist" ;
  schema:jobTitle "Dermato-oncologist and trial lead" ;
  onco:cancers <https://onco.cc/cancers/braf-v600-melanoma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:trials <https://onco.cc/trials/imspire150/> .